EBITDA Margin ratio Analysis of Longboard Pharmaceuticals Inc - Deep Dive


Latest FY EBITDA Margin
Period Ending - Dec-23

0


Poor EBITDA Margin
Period Ending - Dec-22
0

Poor EBITDA Margin
Growth
0 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23

-786312.50


Very Poor EBITDA Margin
Most recent Quarter EBITDA Margin
Period Ending - Mar-24

0


Poor EBITDA Margin
EBITDA Margin Analysis of Longboard Pharmaceuticals Inc
Ebitda Margin Ratio of Longboard Pharmaceuticals Inc with value of -786312.50 means that its operating expenses are Higher in relation to total revenue in trailing twelve months.
Ebitda Margin Ratio of Longboard Pharmaceuticals Inc with value of 0 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24.
EBITDA Margin Ratio of LBPH has fallen by 0 % Compared to previous Financial Year.
Ebitda Margin of Longboard Pharmaceuticals Inc is negative because of negative EBITDA in Trailing Twelve Months ended on Mar-24.
Other EBITDA Margin Related Info of LBPH that may interest you.
Longboard Pharmaceuticals Inc Overview
CodePricePrevious PricePrice ChangeSector
LBPH18.8717.9 5.42 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization.   more ..
EBITDA Margin Formula

EBITDA Margin Related Ratios
NetProfitMarginReturnOnEquity

Tsr Profitability Index
Poor Profitability Stock
FY - Historical EBITDA Margin of Longboard Pharmaceuticals Inc
PeriodDec-23Dec-22Dec-21Dec-20
EBITDA Margin0000
Change
FY Chart of EBITDA Margin of Longboard Pharmaceuticals Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)